ID26083A - Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns - Google Patents

Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns

Info

Publication number
ID26083A
ID26083A IDW20002168A ID20002168A ID26083A ID 26083 A ID26083 A ID 26083A ID W20002168 A IDW20002168 A ID W20002168A ID 20002168 A ID20002168 A ID 20002168A ID 26083 A ID26083 A ID 26083A
Authority
ID
Indonesia
Prior art keywords
paroxoxine
kamforsulfonate
cns
interference
treatment
Prior art date
Application number
IDW20002168A
Other languages
English (en)
Inventor
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID26083A publication Critical patent/ID26083A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20002168A 1998-04-25 1999-04-23 Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns ID26083A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
ID26083A true ID26083A (id) 2000-11-23

Family

ID=10831008

Family Applications (2)

Application Number Title Priority Date Filing Date
IDW20002168A ID26083A (id) 1998-04-25 1999-04-23 Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns
IDW20002169A ID26654A (id) 1998-04-25 1999-04-23 Paroksetin askorbat

Family Applications After (1)

Application Number Title Priority Date Filing Date
IDW20002169A ID26654A (id) 1998-04-25 1999-04-23 Paroksetin askorbat

Country Status (20)

Country Link
EP (1) EP1089995A1 (id)
JP (1) JP2002513019A (id)
KR (1) KR20010042977A (id)
CN (1) CN1297448A (id)
AP (1) AP2000001963A0 (id)
AU (1) AU3618499A (id)
BG (1) BG104940A (id)
BR (1) BR9909868A (id)
CA (1) CA2330055A1 (id)
EA (1) EA200001104A1 (id)
GB (1) GB9808896D0 (id)
HU (1) HUP0102116A3 (id)
ID (2) ID26083A (id)
IL (1) IL139081A0 (id)
NO (1) NO20005352D0 (id)
PL (1) PL343677A1 (id)
SK (1) SK15912000A3 (id)
TR (1) TR200003084T2 (id)
WO (1) WO1999055698A1 (id)
ZA (1) ZA200005912B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
CA2471144C (en) 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
CN118267895A (zh) * 2018-10-30 2024-07-02 中国科学院化学研究所 一种制备药物或药物中间体无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
ZA200005912B (en) 2001-12-19
PL343677A1 (en) 2001-08-27
CN1297448A (zh) 2001-05-30
BR9909868A (pt) 2000-12-19
SK15912000A3 (sk) 2001-04-09
WO1999055698A1 (en) 1999-11-04
JP2002513019A (ja) 2002-05-08
CA2330055A1 (en) 1999-11-04
HUP0102116A2 (hu) 2002-05-29
BG104940A (bg) 2001-09-28
ID26654A (id) 2001-01-25
AP2000001963A0 (en) 2000-12-31
GB9808896D0 (en) 1998-06-24
HUP0102116A3 (en) 2002-12-28
EP1089995A1 (en) 2001-04-11
EA200001104A1 (ru) 2001-04-23
TR200003084T2 (tr) 2001-02-21
KR20010042977A (ko) 2001-05-25
NO20005352L (no) 2000-10-24
AU3618499A (en) 1999-11-16
NO20005352D0 (no) 2000-10-24
IL139081A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
NO20012995D0 (no) Forbindelse nyttige for behandling av inflammatoriske sykdommer
ID27092A (id) Pembuatan ftalat anhidrida
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
ID26990A (id) Metode pembuatan dimetilnaftalena
ID27191A (id) Metode untuk pengobatan insomnia
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
ID17723A (id) Senyawa untuk pengobatan
ID25901A (id) Proses pembuatan 4-aminometil-pirolidin-3-on terlindung
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS4789A (is) Meðferðarefnasambönd
NO20003211D0 (no) Triazinforbindelser for behandling av CNS forstyrrelser
FI990509L (fi) Häiriönpoistomenetelmä
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
FI981975L (fi) Johtuvien häiriöiden suodatuksen optimointi
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
ID24327A (id) Produksi senyawa-senyawa avermektin
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
ID21920A (id) 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20006383L (no) Fremgangsmåte for behandling
PT1088010E (pt) Producao de poliolefinas
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
NO20006382D0 (no) Fremgangsmåte for behandling av organofosfatforgiftning